Costs and Expenses of InMed Pharmaceuticals Inc. from 30 Sep 2021 to 31 Mar 2023

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: InMed Pharmaceuticals Inc. quarterly Costs and Expenses in USD history and change rate from 30 Sep 2021 to 31 Mar 2023.
InMed Pharmaceuticals Inc. Costs and Expenses for the quarter ending 31 Mar 2023 was $2,341,719, a 37% increase year-over-year.
Source SEC data: View on sec.gov

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Change (%)

InMed Pharmaceuticals Inc. Quarterly Costs and Expenses (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2023		$2,341,719	+$1,380,183	+37%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2023	2023	Q3
Q4 2022		$2,365,284	+$2,058,369	+47%	01 Oct 2022	31 Dec 2022	10-Q	17 Feb 2023	2023	Q2
Q3 2022		$3,830,988	+$859,373	+29%	01 Jul 2022	30 Sep 2022	10-Q	14 Nov 2022	2023	Q1
Q1 2022		$3,721,902			01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q3
Q4 2021		$4,423,653			01 Oct 2021	31 Dec 2021	10-Q	17 Feb 2023	2023	Q2
Q3 2021		$2,971,615			01 Jul 2021	30 Sep 2021	10-Q	14 Nov 2022	2023	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.